Ottawa, Canada

Cláudio Rodrigues


Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Claudio Rodrigues: Innovator in Remote Access Technology

Introduction

Claudio Rodrigues is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of remote access technology, holding a total of 8 patents. His work focuses on enhancing the efficiency and security of remote access systems.

Latest Patents

One of Claudio's latest patents is titled "Connecting to remote access session based on proximity of mobile device." This innovative method involves storing client information that identifies a client device and its location. It also includes identifying a remote access session that allows the client device to access resources of the remote access system. The method further entails receiving access information that indicates successful authentication of a user account by an access device. In response to this information, the client device is enabled to connect to the remote access session as a background process while the user interface remains locked.

Career Highlights

Claudio Rodrigues is currently employed at Parallels International GmbH, where he continues to develop cutting-edge solutions in remote access technology. His expertise and innovative mindset have positioned him as a key player in his field.

Collaborations

Claudio has collaborated with notable colleagues such as Nikolay Dobrovolskiy and Serguei M Beloussov. These partnerships have fostered a creative environment that encourages the development of groundbreaking technologies.

Conclusion

Claudio Rodrigues exemplifies the spirit of innovation in the realm of remote access technology. His patents and contributions continue to shape the future of how users connect to remote systems securely and efficiently.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…